Editing ImClone Systems (section)

{{Short description|Biopharmaceutical company}}
{{Infobox company
| name = ImClone LLC
| homepage = [https://web.archive.org/web/20080914211723/http://www.imclone.com:80/index.php www.imclone.com]
| type = [[Subsidiary]]
| traded_as = {{NASDAQ was|IMCL}}
| foundation = {{Start date and age|1984}}
| parent = [[Eli Lilly and Company]]
| num_employees = 1,128
| industry = {{Unbulleted list|[[:Category:Biotechnology companies|Biotechnology company]]|[[:Category:Pharmaceutical industry|Pharmaceutical industry]]}}
}}

'''ImClone Systems LLC''' was a [[biopharmaceutical]] company dedicated to developing [[Medicine|biologic medicines]] in the area of [[oncology]].<ref name=":0">{{cite web|url = http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=325880|title = ImClone Systems Corporation|access-date = 2013-12-25|website = Company Insight Center|publisher = Bloomberg Businessweek|at = Snapshot| archive-url = https://web.archive.org/web/20090518130747/http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=325880 | archive-date = 2009-05-18| url-status=dead}}</ref> It was founded in 1984 and had its corporate headquarters in [[Bridgewater, New Jersey]], and its research headquarters in [[New York City]].<ref name=":0" /> On October 6, 2008, it accepted a $6.5 billion acquisition offer from [[Eli Lilly and Company]], and became a fully-owned subsidiary of Eli Lilly and Company on November 24, 2008. Prior to the acquisition, it was traded on the [[NASDAQ]] stock exchange under the symbol '''IMCL'''. Imclone lost its separate identity in 2014 when its former ImClone research and manufacturing sites were renamed as ''Eli Lilly and Company''.<ref>{{cite web|title=Eli Lilly US Locations|url=https://www.lilly.com/our-us-locations|website=R&D Locations|publisher=Eli Lilly and Company|access-date=19 October 2018|archive-url=https://web.archive.org/web/20181020011920/https://www.lilly.com/our-us-locations|archive-date=20 October 2018|url-status=dead}}</ref>